−1.15 NOK
−53.10 M NOK
1.19 M NOK
6.76 M
About INIFY LABORATORIES AB
Sector
Industry
CEO
Fredrik Palm
Website
Headquarters
Solna
Founded
2021
ISIN
SE0017486103
FIGI
BBG0189Y39P7
INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. It offers services to urologists and hospitals with short and repeatable response time in terms of a structured diagnosis report sent directly into electronic health record system. The company was founded on November 10, 2021 and is headquartered in Solna, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INIFY is 5.20 NOK — it has increased by 0.97% in the past 24 hours. Watch INIFY LABORATORIES AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange INIFY LABORATORIES AB stocks are traded under the ticker INIFY.
INIFY stock has risen by 16.07% compared to the previous week, the month change is a 23.81% rise, over the last year INIFY LABORATORIES AB has showed a −59.38% decrease.
INIFY reached its all-time high on Jul 7, 2023 with the price of 17.00 NOK, and its all-time low was 4.00 NOK and was reached on Nov 25, 2024. View more price dynamics on INIFY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INIFY stock is 4.42% volatile and has beta coefficient of 0.90. Track INIFY LABORATORIES AB stock price on the chart and check out the list of the most volatile stocks — is INIFY LABORATORIES AB there?
Yes, you can track INIFY LABORATORIES AB financials in yearly and quarterly reports right on TradingView.
INIFY net income for the last quarter is −12.23 M NOK, while the quarter before that showed −13.67 M NOK of net income which accounts for 10.52% change. Track more INIFY LABORATORIES AB financial stats to get the full picture.
No, INIFY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 22.00 employees. See our rating of the largest employees — is INIFY LABORATORIES AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INIFY LABORATORIES AB EBITDA is −50.09 M NOK, and current EBITDA margin is −4.31 K%. See more stats in INIFY LABORATORIES AB financial statements.
Like other stocks, INIFY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INIFY LABORATORIES AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INIFY LABORATORIES AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INIFY LABORATORIES AB stock shows the sell signal. See more of INIFY LABORATORIES AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.